Publications

Found 34 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
Journal Article
Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Lu M, Chen Y-CAriel, Qing J, Totpal K, Kan D et al..  2019.  Disruption of IRE1α through its kinase domain attenuates multiple myeloma.. Proc Natl Acad Sci U S A.
Harnoss JM, Le Thomas A, Shemorry A, Marsters SA, Lawrence DA, Lu M, Chen Y-CAriel, Qing J, Totpal K, Kan D et al..  2019.  Disruption of IRE1α through its kinase domain attenuates multiple myeloma.. Proc Natl Acad Sci U S A.
Rauch JN, Valois E, Ponce-Rojas JCarlos, Aralis Z, Lach RL, Zappa F, Audouard M, Solley SC, Vaidya C, Costello M et al..  2020.  CRISPR-based and RT-qPCR surveillance of SARS-CoV-2 in asymptomatic individuals uncovers a shift in viral prevalence among a university population. medRxiv.
Peschek J, Acosta-Alvear D, Mendez AS, Walter P.  2015.  A conformational RNA zipper promotes intron ejection during non-conventional XBP1 mRNA splicing.. EMBO Rep. 16(12):1688-98.
Behrman S, Acosta-Alvear D, Walter P.  2011.  A CHOP-regulated microRNA controls rhodopsin expression.. J Cell Biol. 192(6):919-27.
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA et al..  2016.  Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.. J Clin Invest.
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA et al..  2016.  Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.. J Clin Invest.
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA et al..  2016.  Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.. J Clin Invest.
Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA et al..  2016.  Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.. J Clin Invest.

Pages